NCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
Clinical Trials
5 trialsNCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT00003170 2016-07-14
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01087658 2013-06-21
GLUTOX
Sanofi
Phase 3 Completed
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed